It is increasingly evident that the transition from initiation to transcript elongation by RNA polymerase II is a major regulatory checkpoint in eukaryotic gene expression. During the current support period our laboratory has made significant advances in characterizing this transition. We have devised a working model for promoter clearance, the initial step in this process. Our clearance model includes the novel concept of an important role for transcript initiation factors. We have also demonstrated that a distinct postclearance transition occurs from 25-35 bases downstream of transcription start. Our analysis of the ability of RNA polymerase II to pass through the postclearance stage has suggested new insights into mechanisms through which polymerase can be trapped at this point in transcription. In the current application, we propose four specific aims, through which we will (i) test our initial models for the clearance and postclearance transitions (ii) determine the roles of individual transcription factors in these transitions, and (iii)identify underlying DMA sequences which have important effects on these transitions. Relevance to Public Health: Many genes whose correct expression is essential for human health are controlled through the extended pausing of the transcriptional machinery at a point just after the transcription of genetic information has initiated. It is not currently known how these """"""""regulated gates"""""""" operate. In order to ultimately manipulate these gates for the benefit of human health, it is essential to uncover the molecular mechanisms involved. The research proposed here is aimed at providing this knowledge. The clearance and postclearance transitions which we study are test tube models for the regulatory points observed in the cell.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM029487-26
Application #
7386031
Study Section
Molecular Genetics C Study Section (MGC)
Program Officer
Tompkins, Laurie
Project Start
1981-07-01
Project End
2010-03-31
Budget Start
2008-04-01
Budget End
2009-03-31
Support Year
26
Fiscal Year
2008
Total Cost
$337,544
Indirect Cost
Name
Cleveland Clinic Lerner
Department
Other Basic Sciences
Type
Schools of Medicine
DUNS #
135781701
City
Cleveland
State
OH
Country
United States
Zip Code
44195
Luse, Donal S (2013) Promoter clearance by RNA polymerase II. Biochim Biophys Acta 1829:63-8
Luse, Donal S (2012) Rethinking the role of TFIIF in transcript initiation by RNA polymerase II. Transcription 3:156-9
?abart, Pavel; Luse, Donal S (2012) Inactivated RNA polymerase II open complexes can be reactivated with TFIIE. J Biol Chem 287:961-7
Cabart, Pavel; Ujvari, Andrea; Pal, Mahadeb et al. (2011) Transcription factor TFIIF is not required for initiation by RNA polymerase II, but it is essential to stabilize transcription factor TFIIB in early elongation complexes. Proc Natl Acad Sci U S A 108:15786-91
Újvári, Andrea; Pal, Mahadeb; Luse, Donal S (2011) The functions of TFIIF during initiation and transcript elongation are differentially affected by phosphorylation by casein kinase 2. J Biol Chem 286:23160-7
Ujvari, Andrea; Luse, Donal S (2006) RNA emerging from the active site of RNA polymerase II interacts with the Rpb7 subunit. Nat Struct Mol Biol 13:49-54
Pal, Mahadeb; Ponticelli, Alfred S; Luse, Donal S (2005) The role of the transcription bubble and TFIIB in promoter clearance by RNA polymerase II. Mol Cell 19:101-10
Hawryluk, Peter J; Ujvari, Andrea; Luse, Donal S (2004) Characterization of a novel RNA polymerase II arrest site which lacks a weak 3' RNA-DNA hybrid. Nucleic Acids Res 32:1904-16
Ujvari, Andrea; Luse, Donal S (2004) Newly Initiated RNA encounters a factor involved in splicing immediately upon emerging from within RNA polymerase II. J Biol Chem 279:49773-9
Pal, Mahadeb; Luse, Donal S (2003) The initiation-elongation transition: lateral mobility of RNA in RNA polymerase II complexes is greatly reduced at +8/+9 and absent by +23. Proc Natl Acad Sci U S A 100:5700-5

Showing the most recent 10 out of 37 publications